[经导管主动脉瓣置换术枢纽和辐条网络的发展:IRCCS San Raffaele 医院介入心脏病科的运行模式(OSR Hub-Spoke)]。

IF 0.7 Q4 CARDIAC & CARDIOVASCULAR SYSTEMS
Luca Angelo Ferri, Francesco Federico, Claudio Gentilini, Paolo Bonfanti, Giovanni Corrado, Alfredo Castelli, Mauro Carlino, Marco Ancona, Barbara Bellini, Filippo Russo, Ciro Vella, Domitilla Gentile, Giulia Ghizzoni, Alaide Chieffo, Matteo Montorfano
{"title":"[经导管主动脉瓣置换术枢纽和辐条网络的发展:IRCCS San Raffaele 医院介入心脏病科的运行模式(OSR Hub-Spoke)]。","authors":"Luca Angelo Ferri, Francesco Federico, Claudio Gentilini, Paolo Bonfanti, Giovanni Corrado, Alfredo Castelli, Mauro Carlino, Marco Ancona, Barbara Bellini, Filippo Russo, Ciro Vella, Domitilla Gentile, Giulia Ghizzoni, Alaide Chieffo, Matteo Montorfano","doi":"10.1714/4371.43684","DOIUrl":null,"url":null,"abstract":"<p><p>Recently, an increase in the number of patients with severe aortic stenosis eligible for transcatheter aortic valve implantation (TAVI) has been observed worldwide. In order to reduce waiting lists, provide to all patients referred to us equal access to care and to further improve the collaboration with spoke centers, we developed a specific Hub & Spoke specific protocol for TAVI. According to our protocol, a clinical selection (with echo and computed tomography scan) is done by Spoke centers, the case is discussed with a multidisciplinary team online and the procedure is planned (access, valve type size). At day 0, the patient is admitted in Spoke centers where blood samples are taken; at day 1, the patient is transferred to a Hub center for the TAVI procedure and after 2 h of observation, if no adverse events are registered, the patient is transferred back to the Spoke center. Since 2019, an agreement among our center and two hospitals has been signed. According to this Hub & Spoke model, a total of 72 patients with aortic stenosis were treated with TAVI (mean age 83 years, 48.6% female, median Society of Thoracic Surgeons risk 2.4 ± 1.1%, left ventricular ejection fraction 58.0 ± 7.75%). More frequently CoreValve Evolut R (47.2%) was used. Only 2 patients had a prolonged admission at Hub and were not transferred at day 1 (1 vascular complication and 1 intra-procedural resuscitated cardiac arrest). This Hub & Spoke model guaranteed shortening of waiting lists, more effective turnover of bed, equal access to care to patients referred to our center. In addition, it helped also to increase Awareness and education as well as appropriate training of the teams from spoke facilities.</p>","PeriodicalId":12510,"journal":{"name":"Giornale italiano di cardiologia","volume":"25 11","pages":"24S-28S"},"PeriodicalIF":0.7000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[The development of a Hub & Spoke network for transcatheter aortic valve replacement procedures: the operational model of the Interventional Cardiology Unit at the IRCCS San Raffaele Hospital (OSR Hub-Spoke)].\",\"authors\":\"Luca Angelo Ferri, Francesco Federico, Claudio Gentilini, Paolo Bonfanti, Giovanni Corrado, Alfredo Castelli, Mauro Carlino, Marco Ancona, Barbara Bellini, Filippo Russo, Ciro Vella, Domitilla Gentile, Giulia Ghizzoni, Alaide Chieffo, Matteo Montorfano\",\"doi\":\"10.1714/4371.43684\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Recently, an increase in the number of patients with severe aortic stenosis eligible for transcatheter aortic valve implantation (TAVI) has been observed worldwide. In order to reduce waiting lists, provide to all patients referred to us equal access to care and to further improve the collaboration with spoke centers, we developed a specific Hub & Spoke specific protocol for TAVI. According to our protocol, a clinical selection (with echo and computed tomography scan) is done by Spoke centers, the case is discussed with a multidisciplinary team online and the procedure is planned (access, valve type size). At day 0, the patient is admitted in Spoke centers where blood samples are taken; at day 1, the patient is transferred to a Hub center for the TAVI procedure and after 2 h of observation, if no adverse events are registered, the patient is transferred back to the Spoke center. Since 2019, an agreement among our center and two hospitals has been signed. According to this Hub & Spoke model, a total of 72 patients with aortic stenosis were treated with TAVI (mean age 83 years, 48.6% female, median Society of Thoracic Surgeons risk 2.4 ± 1.1%, left ventricular ejection fraction 58.0 ± 7.75%). More frequently CoreValve Evolut R (47.2%) was used. Only 2 patients had a prolonged admission at Hub and were not transferred at day 1 (1 vascular complication and 1 intra-procedural resuscitated cardiac arrest). This Hub & Spoke model guaranteed shortening of waiting lists, more effective turnover of bed, equal access to care to patients referred to our center. In addition, it helped also to increase Awareness and education as well as appropriate training of the teams from spoke facilities.</p>\",\"PeriodicalId\":12510,\"journal\":{\"name\":\"Giornale italiano di cardiologia\",\"volume\":\"25 11\",\"pages\":\"24S-28S\"},\"PeriodicalIF\":0.7000,\"publicationDate\":\"2024-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Giornale italiano di cardiologia\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1714/4371.43684\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Giornale italiano di cardiologia","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1714/4371.43684","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

摘要

最近,全球符合经导管主动脉瓣植入术(TAVI)条件的重度主动脉瓣狭窄患者人数有所增加。为了减少候诊人数,为所有转诊患者提供平等的治疗机会,并进一步改善与辐照中心的合作,我们制定了经导管主动脉瓣置换术(TAVI)的 "枢纽与辐照"(Hub & Spoke)特定方案。根据我们的方案,转运中心进行临床选择(通过回声和计算机断层扫描),与多学科团队在线讨论病例,并计划手术(入路、瓣膜类型大小)。第 0 天,患者在 Spoke 中心住院并采集血样;第 1 天,患者被转至 Hub 中心进行 TAVI 手术,观察 2 小时后,如果没有出现不良事件,患者将被转回 Spoke 中心。自 2019 年起,本中心与两家医院签署了一项协议。根据这种 Hub & Spoke 模式,共有 72 名主动脉瓣狭窄患者接受了 TAVI 治疗(平均年龄 83 岁,48.6% 为女性,胸外科医师协会风险中位数为 2.4 ± 1.1%,左室射血分数为 58.0 ± 7.75%)。使用较多的是CoreValve Evolut R(47.2%)。只有两名患者在 Hub 的入院时间较长,没有在第 1 天转院(1 名血管并发症患者和 1 名术中复苏心脏骤停患者)。这种 "枢纽与辐条 "模式保证了候诊时间的缩短、床位的更有效周转以及转诊到本中心的病人获得平等的治疗机会。此外,这种模式还有助于加强宣传和教育,以及对来自辐射机构的团队进行适当的培训。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
[The development of a Hub & Spoke network for transcatheter aortic valve replacement procedures: the operational model of the Interventional Cardiology Unit at the IRCCS San Raffaele Hospital (OSR Hub-Spoke)].

Recently, an increase in the number of patients with severe aortic stenosis eligible for transcatheter aortic valve implantation (TAVI) has been observed worldwide. In order to reduce waiting lists, provide to all patients referred to us equal access to care and to further improve the collaboration with spoke centers, we developed a specific Hub & Spoke specific protocol for TAVI. According to our protocol, a clinical selection (with echo and computed tomography scan) is done by Spoke centers, the case is discussed with a multidisciplinary team online and the procedure is planned (access, valve type size). At day 0, the patient is admitted in Spoke centers where blood samples are taken; at day 1, the patient is transferred to a Hub center for the TAVI procedure and after 2 h of observation, if no adverse events are registered, the patient is transferred back to the Spoke center. Since 2019, an agreement among our center and two hospitals has been signed. According to this Hub & Spoke model, a total of 72 patients with aortic stenosis were treated with TAVI (mean age 83 years, 48.6% female, median Society of Thoracic Surgeons risk 2.4 ± 1.1%, left ventricular ejection fraction 58.0 ± 7.75%). More frequently CoreValve Evolut R (47.2%) was used. Only 2 patients had a prolonged admission at Hub and were not transferred at day 1 (1 vascular complication and 1 intra-procedural resuscitated cardiac arrest). This Hub & Spoke model guaranteed shortening of waiting lists, more effective turnover of bed, equal access to care to patients referred to our center. In addition, it helped also to increase Awareness and education as well as appropriate training of the teams from spoke facilities.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Giornale italiano di cardiologia
Giornale italiano di cardiologia CARDIAC & CARDIOVASCULAR SYSTEMS-
CiteScore
1.10
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信